The investigators will evaluate the implementation of a treatment bundle (Fibrinogen, Plasma and Tranexamic Acid)
The investigators will perform a prospective observational study of patients in haemorrhagic shock with suspected life threatening bleeding from trauma, treated by the prehospital emergency doctor response team of the Medical University of Graz and the HEMS (Helicopter Emergency Medical Service) of Graz according to their SOPs. Only patients that are being transported to the resuscitation room of the Medical University of Graz after prehospital transfusion will be included. The SOPs for prehospital transfusion are being implemented for the treatment of patients in extremis because of suspected life-threatening traumatic bleeding in the above-mentioned emergency services, according to the manufacturer's requirements. These transfusion SOPs are already part of the standard of care in the resuscitation room of the Medical University of Graz. This study seeks to gather information on the benefits and potential harms of this change of prehospital clinical routine. The treatment bundle will include 2 units of Fibrinogen and Plasma in addition to 10-20 mg/kg Tranexamic Acid
Study Type
OBSERVATIONAL
Enrollment
10
Medical University of Graz
Graz, Austria
RECRUITINGNumber of patients with successful prehospital bundle transfusion
to assess feasibility
Time frame: prehospital setting
30-day-mortality
Time frame: 30 days
blood product used in the first 24 hours
Time frame: 24 hours
concentration of lactat acid ad admission
measured in the emergency department
Time frame: 2 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.